Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Online First

FDA Oncology Update

Omisirge FDA Approved for Patients with Hematologic Malignancies to Reduce Time to Neutrophil Recovery and Infection

Original Article

Retrospective Evaluation of Initial Empiric Double Coverage with Tobramycin in Adult Patients with Febrile Neutropenia

Amber B. Clemmons, PharmD, BCOP, FHOPA; Rachel Shelley, PharmD; Vayou Chittavong, MS, PharmD; Huimin Hu, PhD; Xianyan Chen, PhD; Joshua Eudy, PharmD, BCIDP; Andrew Chao, MD; Daniel T. Anderson, PharmD, BCIDP

Original Article

Stopping Oral Chemotherapy Agents with a High Bleeding Risk Before and After Minor Surgical Procedures

Dennis Marjoncu, PharmD, BCOP; Jenna Carmichael, PharmD, BCOP; Benjamin J. Andrick, PharmD, BCOP; Jacqueline Oxenberg, DO, FACS, FACOS

FDA Oncology Update

Padcev plus Keytruda Granted Accelerated FDA Approval for Locally Advanced or Metastatic Urothelial Carcinoma

Results 1 - 4 of 4